Government Reform chair
This article was originally published in The Tan Sheet
Tom Davis (R-Va.) replaces Dan Burton (R-Ind.) as chairman of the House Government Reform Committee. Under Burton, committee held hearings on a variety of topics related to the dietary supplement industry, including ephedra, adverse event reporting...
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."